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Introduction
Ultrasound (US) of the thyroid is well established 
for a variety of indications and applications. US is the 
most sensitive imaging test available for the examina-
tion of the thyroid gland, to detect and characterize le-
sions, accurately calculate their dimensions, identify 
the internal structure and vascularization using color 
Doppler imaging (CDI) and evaluate diffuse changes 
in the thyroid parenchyma. Thyroid US is able to con-
firm the presence of a thyroid nodule when the physi-
cal examination is equivocal and differentiate between 
thyroid nodules and cervical masses from other origins 
[1,2]. In this setting, the accurate differentiation of be-
nign from malignant lesions is critical to ensure that the 
patient undergoes the appropriate diagnostic and thera-
peutic decision.
In the present two part papers, the role of ultrasound 
techniques in the evaluation of diffuse thyroid disease 
(DTD) (Part 1) and characterization of focal thyroid le-
sions (FTL) (Part 2) is described to accompany the re-
cently published WFUMB thyroid elastography guide-
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lines and review how the guidelines fit into a complete 
thyroid ultrasound exam. 
Clinical indications according to guidelines
Thyroid ultrasound is recommended in [1,2]: 
1. All patients with a palpable thyroid nodule or with 
multinodular goiter. 
2. High-risk patients for thyroid malignancy: history 
of familial thyroid cancer, multiple endocrine neo-
plasia (MEN) type II and irradiated neck in child-
hood.
3. Patients with palpable cervical adenopathy suspi-
cious for malignancy. 
4. Follow-up and monitoring thyroid nodules.
Thyroid ultrasound is not recommended in [1,2]: 
1. Patients with a normal thyroid on palpation and 
low risk of thyroid cancer.
2. As a screening test in the general population.
Examination technique
The recommended protocol for thyroid US is as fol-
lows [3,4] (Table I):
1. Patient is scanned in supine position with neck ex-
tended with a small pillow or rolled towel behind 
the shoulders.
2. Axial scans of the whole gland at the upper, mid, 
lower poles and the isthmus, and side-by-side im-
ages of each lobe, to compare echogenicity and 
size of both lobes. Each lobe width and AP diam-
eters are measured.
3. Longitudinal scans through each lobe, on medial, 
mid and lateral planes. The length of the lobes is 
measured.
4. Identify focal lesions, measure the main lesions 
and identify the dominant one (according to size).
5. Evaluation of vascularization using CDI of both 
lobes and any lesions if detected.
6. Document the presence of enlarged lymph nodes 
[5,6] or thrombosed jugular vein. 
Nodules with any malignant potential (essentially all 
nodules except pure cysts) should be identified [3,7]. 
The value of thyroid ultrasound examination
The value of thyroid ultrasound examination is as fol-
lows: 
1. To detect FTL;
2. To differentiate between benign and malignant 
FTL;
3. To evaluate cervical lymphadenopathy;
4. To guide interventions, e.g., biopsy and percu-
taneous treatment;
5. To assess change in size of thyroid nodules with 
follow up US.
In all patients with palpable thyroid nodules, US 
should be performed to accomplish the following [3]:
1. Detect US features suggestive of malignant growth 
and select the lesions to be recommended for fine-
needle aspiration (FNA);
2. Look for coincidental thyroid nodules;
3. Help with the diagnosis in difficult cases (as in 
Hashimoto’s thyroiditis);
4. Choose the gauge and length of the biopsy needle;
5. Obtain an objective measure of the baseline vol-
ume and characteristics of the lesions that will be 
assigned to follow-up or medical or minimally in-
vasive therapy – Radiofrequency ablation (RFA), 
Microwave ablation (MWA), Laser.
Indications for thyroid US, following the American 
Association of Clinical Endocrinologists (AACE) are as 
follows [8]:
1. To confirm presence of a thyroid nodule when 
physical examination is equivocal.
2. To characterize a thyroid nodule(s), i.e. to measure 
the dimensions accurately and to identify internal 
structure and vascularization.
3. To differentiate between benign and malignant 
thyroid masses, based on their sonographic ap-
pearance.
4. To differentiate between thyroid nodules and other 
cervical masses like lymphadenopathy, thyroglos-
sal cyst and cystic hygroma.
5. To evaluate diffuse changes in thyroid parenchyma.
6. To detect post-operative residual or recurrent tumor 
in thyroid bed or metastases to neck lymph nodes.
7. To screen high-risk patients for thyroid malig-
nancy like patients with history of familial thyroid 
cancer, MEN type II and irradiated neck in child-
hood.
8. To guide diagnostic (FNA cytology/biopsy) and 
therapeutic interventional procedures.
TIRADS (thyroid imaging reporting and data 
system) – Classification
In the last few years, assessment concepts called as 
‘grading system’ or ‘reporting system’ have emerged. In 
Table I. Standardized structured US reporting criteria for thy-
roid evaluation. 
Thyroid gland Thyroid nodules
Position Size / Location
Shape Margins
Size Composition (solid, cystic, spongiform, 
proportion)
Content Presence and type of calcifications
Echogenicity Echogenicity iso/hyper/hypo
Vascular pattern Vascular pattern
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a way similar to BIRADS (Breast Imaging-Reporting 
and Data System) these systems were named “Thy-
roid Imaging Reporting and Data System” or TIRADS. 
Thyroid nodules were classified into categories related to 
their US patterns and indications for FNA were based on 
these categories calculating a qualitative risk [9]. How-
ever, these systems are time consuming, somewhat cum-
bersome and interobserver agreement is reported to be 
quite low [10]. For this reason subsequent studies tried to 
simplify the systems.
In 2011, Kwak et al developed a practical TIRADS 
with which to categorize thyroid nodules and stratify 
their malignant risk. The following US features showed 
a significant association with malignancy: solid compo-
nent, hypoechogenicity, marked hypoechogenicity, mi-
crolobulated or irregular margins, microcalcifications, 
and taller-than-wide shape [11].
When reporting a thyroid ultrasound, some general 
rules should be fulfilled: 
1. Describe sonographic appearance of the thyroid 
gland and structural, shape and size alterations as 
shown above. 
2. Describe the imaging characteristics of the nodule 
as shown in table I. 
3. Identify the nodule at risk to be malignant by 
risk stratification based on identification of high 
risk factors [12]. 
4. The proposed risk stratification system based 
on solidity and echogenicity will be useful for risk 
stratification and management decision of thyroid 
nodules [13]. 
5. Additional evaluation of the nodule with elas-
tography can be performed, if available.
Clinical work up
In the clinical work up of thyroid nodules, there are 
some main questions should be asked:
1. Is the nodule suspicious for malignancy?
2. Is there a history of MEN II, previous neck radia-
tion or thyroid resection?
3. Are cervical lymph nodes involved?
4. Is there a primary focus in the thyroid gland in a 
patient with cervical adenopathy? 
5. Is there a post-operative residual or recurrent tumor in 
the thyroid bed or metastases to neck lymph nodes?
In case of a positive answer to any of the above 
questions, FNA must be performed. Recommendations 
for FNA of thyroid nodules based on US features were 
published by the American Thyroid Association (ATA) 
in 2015 [2].
The TIRADS classification is shown in Table II [9]. 
Normal size, shape, echogenicity 
The normal thyroid gland consists of two lobes and 
a bridging isthmus. Thyroid size, shape, and volume 
vary with age and sex. The normal thyroid gland (fig 1) 
weighs approximately 30 g but the size and shape vary 
according to age [14]. 
When the gland enlarges, it may extend inferiorly 
into the superior mediastinum and is then described as a 
retrosternal thyroid. The volume of the thyroid gland is 
quite important for clinical practice since it identifies the 
enlargement of the thyroid gland (goiter) and its response 
to suppressive therapy. For the treatment of Graves’ dis-
ease it allows a rigorous calculation of the appropriate 
radio-iodine dose. Diminution of the thyroid volume 
(thyroid atrophy) can be detected in some cases, but has 
less clinical importance. Normal thyroid lobe dimensions 
are: 18-20 mm longitudinal and 8-9 mm antero-posterior 
(AP) diameter in newborn; 25 mm longitudinal and 12-
15 mm AP diameter at one year age; and 40-60 mm lon-
gitudinal and 13-18 mm AP diameter in adult population. 
Measurement of the thyroid lobe involves three meas-
urements: the width, depth and length, then the volume 
is calculated by the formula V = W x D x L x 0.523 (V-
volume, W-width, D-depth, L-length). The total volume 
Table II. TIRADS classification [9].
Category 1 2 3 4 5 6
Definition Normal thy-
roid gland
Benign Probably 
benign
Suspicious for malignancy Probably ma-
lignant
Biopsy proven 
malignancy4a 4b 4c
Number of suspi-
cious features
One Two 3-4 All 5
Fig 1. Normal thyroid gland. Transverse ultra-
sound through the neck shows that the normal 
thyroid consists of two lobes and a bridging 
isthmus with a homogenous appearance on ul-
trasound.
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results from the sum of the two volumes; the isthmus is 
omitted, unless its thickness is over 3 mm. The limits of 
normal thyroid volume are 10-15 ml for females and 12-
18 ml for males. The width and depth are measured on 
transverse section of the lobe: the width is the distance 
between the most lateral point of the lobe and the acous-
tic shadowing of the trachea and the depth is the maxi-
mum antero-posterior distance in the middle third of the 
lobe (fig 2) [15].
In some cases, on the upper margin of the isthmus 
there is an accessory lobe (Lalouette pyramid), which 
must be identified and measured, and the volume must be 
added to that of the lobes [16]. 
The structure of the thyroid gland is granulated 
(ground glass appearance) and the echogenicity is similar 
to that of the parotid glands, and of increased echogenic-
ity compared to that of the adjacent muscles [15]. The re-
lationships with surrounding structures are: sternocleido-
mastoid and strap muscles anteriorly; trachea/esophagus 
and longus colli muscles posteriorly; and common ca-
rotid arteries and jugular veins bilaterally (fig 2) [17,18].
Congenital anomalies
Congenital agenesis or hypoplasia of the thyroid 
gland may include the whole gland or just one of the lobes 
[19]. Congenital hypothyroidism is a relatively common 
endocrine disorder [20]. Approximately 80% of congeni-
tal hypothyroidism is caused by thyroid dysgenesis due 
to absence, hypoplasia or ectopia of the gland, which is 
almost always sporadic in nature [21]. Ectopic thyroid 
tissue is derived from incomplete migration of thyroid 
gland and can be found anywhere along the migration 
course of the thyroid primordium [22] which is between 
the base of tongue and pretracheal region. The most com-
mon presentation is a euthyroid neck mass [23]. Ectopic 
thyroid tissue most commonly appears in the midline in 
the cervical region (90 % of the cases) [24]. Appearance 
varies on US, but the tissue is generally located close to 
the hyoid bone (fig 3) [20]. Its prevalence is approxi-
mately 1/100,000 – 1/300,000 [25].
Tips and tricks: Scintigraphy is more sensitive than 
US for detecting an ectopic thyroid. Scintigraphy pro-
vides functional information of the thyroid which is not 
available based on ultrasound examination alone. The 
thyroid gland appears normal on US in patients with hy-
poplasia; however, scintigraphy reveals decreased iso-
tope uptake [20].
Diffuse thyroid disease (DTD)
A wide spectrum of DTDs affect the thyroid gland 
with the most common being autoimmune thyroid dis-
ease (AITD). Hashimoto’s thyroiditis and Graves’ dis-
ease are the most common AITDs. US is not generally 
required for the diagnosis of DTD and diagnosis is based 
on presenting symptoms, laboratory analysis of thyroid 
function, immunology, and occasionally radioactive io-
dine uptake scans [26]. Radioiodine scans are neither 
needed nor recommended to diagnose Hashimoto or 
Graves’ disease. In some cases, like Hashimoto’s thy-
roiditis, the disease is primarily subclinical and US is 
helpful in detecting these patients. In addition, US helps 
exclude focal thyroid disease in these patients and in as-
sessing the size of the thyroid gland.
Ultrasonography findings indicative of DTD are char-
acterized by a diffusely enlarged or normal size thyroid 
gland or small size in later stages of DTD, decreased or 
increased diffuse heterogeneous parenchymal echogenic-
ity, a coarse echotexture, and micronodulation [27,28]. 
In theory, differentiation with ultrasound elastogra-
phy is feasible because of the different pathologic fea-
Fig 2. Thyroid lobe, transverse image through 
the left lobe – note the relationships of the 
surrounding structures: sternocleidomastoid 
(SCM) and strap muscles (SM) anteriorly; tra-
chea (Tr)/esophagus (Eso) and longus colli mus-
cles (LCM) posteriorly; and common carotid 
arteries (CA) and jugular veins (JV) bilaterally.
Fig 3. Ectopic thyroid – 24 year old with a known ectopic 
thyroid with a growing mass at the base of the tongue – note 
absence of the normal thyroid gland in the neck seen on trans-
verse image through the neck (a) and presence of a hypoechoic 
rounded mass (P) in the base of the tongue (A). This mass was 
biopsied and was consistent with a benign adenoma.
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tures and stiffness. Yang et al in their study found that 
the strain ratio (SR) values (calculated by comparing the 
strain in the thyroid nodule to the sternocleiodomastoid 
muscle in the same image) ranked in ascending order, 
control group < hyperthyroidism group < Hashimoto’s 
thyroiditis group < subacute thyroiditis group with sta-
tistically significant difference (p<0.05) between groups 
and that it is feasible to assess diffuse thyroid disease 
with strain ratios obtained with ultrasound elastography 
[29]. In clinical practice, elastography is usually not used 
for these indications.
Goiter, Struma diffusa
Generalized enlargement of the thyroid is called 
goiter and can be diffuse or nodular. It may be within 
a range from simple diffuse nontoxic non-nodular thy-
roid enlargement to multinodular goiter in a euthyroid 
patient. The cause of simple goiter is multifactorial and 
involves complex interactions between environmental 
(iodine intake), genetic, and endogenous (female gen-
der) factors [30]. Insufficient thyroid hormone input is 
the most frequent cause worldwide except for the Unit-
ed States; it begins as reaction with follicular epithelium 
compensatory hypertrophy which generates ordinary, 
polyclonal follicles alternating with scarring caused by 
hemorrhagic necrosis over the course of goiter growth 
in an attempt to maintain a euthyroid state [31,32]. At 
conventional B-mode US and CDI multinodular goiter 
frequently appears as thyroid enlargement with focal 
or diffuse replacement of the thyroid parenchyma by 
strictly adjacent, sometimes, not distinctive, variable 
echo structure nodules containing variable amount of 
cystic degeneration, vascularization and dystrophic cal-
cifications, without or with minimal normal remaining 
parenchyma (fig 4). In the case of multiple sonographi-
cally similar appearing nodules, representative nodules, 
or nodule clusters when involvement is focal, can be 
identified for measurement to obtain more reproducible 
follow-up [33]. The main aim of ultrasound is to iden-
tify nodules that have malignant sonographic features 
(see TIRADS) to be submitted to ultrasound-guided 
FNA [34].
Elastography 
To date, no specific papers, neither specific recom-
mendation, to the best of our knowledge have been pub-
lished focusing on diffuse goiter. For the specific features 
regarding single nodules please see below.
Contrast enhanced ultrasound 
To date, no specific papers, to the best of our knowl-
edge have been published focusing on diffuse goiter. For 
the specific features regarding single nodules please see 
below.
Tips and tricks
Thyroid scintigraphy is often used in cases where 
the cause of the hyperthyroidism is unclear and to eval-
uate for thyroid nodules before treatment [35]. Society 
of Radiologists in Ultrasound [36] recommend that so-
nographic features of individual nodules in a multinod-
ular gland should be the primary criteria for suggest-
ing biopsy rather than using nodule size. In their recent 
guidelines published in 2015 ATA [2] recommends that 
patients with multiple nodules >1cm should be evaluat-
ed in the same fashion as patients with a solitary nodule 
>1cm with each nodule >1cm carrying an independent 
risk of malignancy. If multiple nodules >1cm are pre-
sent, those with a suspicious sonographic pattern should 
be aspirated preferentially and if none of the nodules 
have a high or moderately suspicious sonographic pat-
tern, nodules greater than 2 cm should be aspirated 
and the rest should undergo follow up with serial US 
examinations [2]. The ATA guidelines use size criteria 
not since there is an increased risk of cancer in larger 
nodules but because lesions with different size have dif-
ferent prognosis.
Thyroiditis
Different causes of thyroiditis have been identified 
including: infection, autoimmune processes, medication, 
and ionizing radiation. As a result of the inflammatory 
process, temporary or permanent impairment of thyroid 
function usually follows. The different forms of thyroidi-
tis may be clearly distinguished on the basis of clinical 
findings, a few laboratory values, and the ultrasound re-
sults [37]. US guided FNA with cytological examination 
is rarely needed. Scintigraphy of the thyroid is usually of 
no added diagnostic value. Impairment of thyroid func-
tion is divided into hyper- and hypothyroidism [38].
The commonest types of thyroiditis encountered are 
Hashimoto’s thyroiditis and de Quervain’s thyroiditis. 
This section will restrict itself to discussion of these two 
conditions in addition to a discussion of Graves’ disease 
[39].
Fig 4. Multinodular goiter. A 43 year old pa-
tient with multinodular goiter and hypothyroid-
ism. Sagittal ultrasound the right lobe showed 
an enlarged thyroid gland with multiple iso- to 
hyperechoic nodules of variable size, however 
similar in appearance.
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a) Hashimoto’s thyroiditis or Chronic Lymphocytic 
thyroiditis 
Hashimoto’s thyroiditis or chronic lymphocytic thy-
roiditis (CLT) is the most common form of organ-specific 
autoimmune diseases [20]. It is the commonest cause of 
hypothyroidism in the United States [27]. Its annual inci-
dence is estimated to be between 0.3 and 1.5 cases per 1000 
persons, with no significant race-related predominance 
[27]. Hashimoto’s thyroiditis affects 1.3% of children and 
has a female predominance [40], with a 8 to 9:1 female 
to male ratio [41]. The disease usually develops in young 
or middle aged women and leads to progressive thyroid 
failure [42]. It is characterized by diffuse interstitial lym-
phocytic infiltration and a variable degree of fibrosis [43]. 
Diagnosis is made by detecting anti-thyroid antibodies, 
including anti-thyroid peroxidase and anti-thyroglobulin 
antibodies [20]. Patients with the acute form present with 
painless, lobular, diffusely enlarged thyroid gland (classi-
cal Hashimoto´s) or – much more common – an atrophic 
thyroid (historically named as Ord´s thyroiditis) [27]. 
Conventional B-mode ultrasound 
Hashimoto’s thyroiditis is primarily a subclinical dis-
ease, and US can detect this subset of patients before they 
come to clinical attention when typical US findings are 
present [44].
US is useful for measuring thyroid size and assessing 
echotexture. Sonographic appearances vary depending on 
the degree of gland involvement, which include severity of 
follicular disruption, lymphocytic infiltration, and chronic-
ity of disease and extent of thyroid involvement. Initially 
the parenchyma is heterogeneous and coarsened compared 
with normal thyroid (fig 5). In some patients, innumerable 
hypoechoic solid micro nodules are seen ranging in size 
from 1 to 7 mm surrounded by echogenic rim of fibrosis. 
This appearance is highly specific with a positive predic-
tive value of 95% [28]. As the disease progresses, thy-
roid parenchyma is progressively destroyed and develops 
echogenic linear bands of parenchymal fibrosis which can 
become confluent and thicker (fig 6). There can be asym-
metric involvement with preference for the anterior part 
of the gland. Eventually the gland becomes atrophic with 
a hypoechoic appearance similar to that of strap muscles.
Color Doppler imaging (CDI)
CDI in Hashimoto’s is variable with either normal 
or increased vascularity seen in the early disease. The 
increase in vascularity seems to be associated with de-
velopment of hypothyroidism [45]. Later in the disease 
course, the gland shows decreased vascularity.
On CDI, the hypertrophic form (Hashimoto’s thy-
roiditis) presents itself with slightly increased vascularity 
(hyperthyroid phase) in the early stages (fig 7a), whereas 
the stage of atrophy is characterized by reduced or absent 
vascularization (fig 7b). During the phase of clinically 
manifest hypothyroidism, vascularization may increase 
once more. Peak systolic velocity (PSV) in the afferent 
arteries is normal in all stages (slightly increased in the 
case of manifest hypothyroidism), thereby facilitating the 
differentiation from Graves’ disease [38].
Elastography 
Sporea et al reported a cut-off value >2.53 m/s using 
shear wave elastography (SWE) for differentiation be-
tween normal thyroid and diffuse thyroid diseases, with 
a positive predictive value >90% [46]. They also found 
a statistically significant difference in velocity values in 
autoimmune pathology with a value of 2.07±0.44 m/s in 
Fig 5. Hashimoto’s thyroiditis – transverse scan through the 
neck shows a heterogeneous thyroid gland with multiple hypo-
echoic areas in it on the Bode image (a) and increased vascular-
ity on the Color Doppler (b) image.
Fig 6. Hashimoto’s thyroiditis with fibrosis – 
Sagittal image through the right lobe shows a 
hypoechoic thyroid lobe with multiple echo-
genic linear strands in it which are consistent 
with fibrosis.
Fig 7. Vascularity in thyroiditis can be variable depending on 
the stage of the disease. a) Sagittal US image through the right 
lobe shows a heterogeneous gland with hypervascularity in it on 
color Doppler which is due to early stage in this patient. b) Dif-
ferent patient with known chronic thyroiditis shows a decreased 
vascularity likely due to the atrophic stage in this patient.
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Graves’ disease compared with 2.68±0.50 m/s in chronic 
autoimmune thyroiditis [47].
Kim et al found a cut-off mean value of the EI (elas-
ticity index) using carotid artery as the internal compres-
sion source, in cases of diffuse thyroid disease, of 27.6 
kPa and a maximum value of 41.3 kPa, with a sensitiv-
ity of 40.9% and a specificity of 82.9% [48]. Magri et 
al studied the EI in patients with chronic autoimmune 
thyroiditis and found that the elasticity of extra nodular 
tissue is decreased according to the thyroid antibody titer 
and the degree of thyroid function damage [49].
Fukuhara et al evaluated the utility of Acoustic Radia-
tion Force Impulse (ARFI) SWE for diagnosing chronic 
autoimmune thyroiditis (CAT) and to verify the effect 
of fibrotic thyroid tissue on SWV. The SWV for CAT 
(2.47±0.57m/s) was significantly higher than that for con-
trols healthy subjects (1.59±0.41 m/s) (p<0.001). AUROC 
for CAT was 0.899, and the SWV cut-off value was 1.96 
m/s. The sensitivity, specificity, and diagnostic accuracy 
were 87.4%, 78.7%, and 85.1%, respectively. Levels of an-
ti-thyroperoxidase antibodies and thyroid isthmus thickness 
were correlated with tissue stiffness in CAT. However, there 
was no correlation between levels of anti-thyroglobulin an-
tibodies and tissue stiffness. Quantitative SWE is useful for 
diagnosing CAT, and it is possible that SWE can be used to 
evaluate the degree of fibrosis in patients with CAT [50].
Magri et al indicated that SWE correctly defines the 
elasticity of thyroid nodules independently from the co-
existence of autoimmune thyroiditis, always being able 
to differentiate nodular tissue from the surrounding pa-
renchyma. In Hashimoto’s thyroiditis the stiffness of ex-
tra-nodular tissue increases in relation to both the thyroid 
antibody titer and the degree of impairment of thyroid 
function [49]. For a cut-off value of 22.3 kPa, which re-
sulted in the highest sum of sensitivity and specificity, 
the EI assessed by SWE had a sensitivity of 59.6% and 
a specificity of 76.9% (AUROC=0.71; p<0.001) for pre-
dicting the presence of autoimmune thyroid disease [51].
However, in clinical practice, elastography is usually 
not needed for these indications.
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on Hashimoto’s thy-
roiditis. For the specific features regarding single nodules 
please see below. 
Tips and tricks 
US guided FNA is an appropriate means of establish-
ing tissue diagnosis and should be used in association 
with appropriate laboratory studies, FNA, demonstrating 
diffuse lymphocytic infiltration, as well as high-titer anti-
bodies against thyroid peroxidase (anti-TPO) (sensitivity 
70-90%) might be helpful in the diagnostics of chronic 
Hashimoto’s thyroiditis in the early stages. The atrophic 
form is characterized by an elevated basal TSH level and 
requires no further laboratory tests or cytological diag-
nostics. Scintigraphy (mottled accumulation pattern and 
low nuclide uptake) provides no additional information 
[38].
b) Graves’ disease
Hyperthyroidism is rare in childhood and is most 
commonly caused by Graves’ disease. It affects 0.02 % 
of children or 1 in 5000 [40]. The peak incidence occurs 
from 11-15 years of age with a female predominance. A 
positive family history is common. Graves’ disease is an 
autoimmune disorder that results in hyper-functioning of 
the thyroid. It is caused by thyroid receptor antibodies 
binding to the thyrotropin receptor (TSH-receptor). The 
typical biochemical thyrotoxic profile is matched by a 
diffuse enlargement of the thyroid gland with rounding 
of the normal angular outline [52]. 
Conventional B-mode ultrasound 
No specific findings are present, however findings 
suggestive of the disease include diffuse enlargement, 
convex bowing of the anterior gland margin and mild 
textural coarsening (fig 8). The echogenicity is often 
decreased due to the increased blood flow, increased 
cellularity and decreased colloid content. Compared to 
Hashimoto’s thyroiditis, the appearance of the thyroid in 
Graves’ disease is less heterogeneous and the contour is 
lobulated [53]. Features of increased volume, hypervas-
cularity, and heterogeneous reduced echogenicity have 
been shown in Graves’ disease [35]. 
Color Doppler imaging 
Normal thyroid parenchyma shows occasional spots 
of flow on color Doppler; peak systolic velocities between 
15 and 30 cm/s in the inferior thyroid artery and 3 to 5 
cm/s in the intrathyroid arteries are considered within the 
range of normal [54]. Increased vascularity and arterio-
venous shunting is called “thyroid inferno” which is sug-
gestive of Graves’ disease (fig 9). Studies have shown that 
Fig 8. Graves’ disease – 30 year old female 
with known Graves’ disease. Sagittal US 
through the right lobe shows an enlarged gland 
with a heterogeneous appearance.
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color and spectral Doppler interrogation can differentiate 
Graves’ disease from other causes of hyperthyroidism 
with high specificity [54]. Patients with untreated, active 
Graves’ disease show markedly increased vascularity at 
color Doppler. Thyroid blood flow (TBF) can present 
clearer information of minute blood flow than traditional 
power Doppler mode and is calculated as an advanced dy-
namic flow/region of interest (ADF/ROI) ratio by special 
software. ADF is a recently developed high-resolution 
power Doppler mode used as a quantitative method for 
calculating TBF. TBF was significantly higher (p<0.0001) 
in Graves’ disease than in painless thyroiditis, subacute 
thyroiditis, or normal controls. The TBF of patients with 
Graves’ disease was consistently >4%, and all other pa-
tients had TBF <4%, indicating that 4% is the cutoff for 
distinguishing destruction-induced thyrotoxicosis and 
Graves’ disease [55]. Patients with Graves’ disease show 
an approximately 15-fold higher TBF measured in mL/
min compared with normal and high peak systolic veloc-
ity flow on spectral Doppler in the medium-sized peri-
thyroid and intra-thyroid  arteries [56].
English et al described the typical sonographic features 
of the thyroid gland in patients with Graves’ hyperthy-
roidism after radioiodine therapy (RIT). The sonographic 
features of the post-RIT gland included a significantly 
reduced mean total volume of 4.2 mL, hypovascularity, 
coarse echotexture, and hyperechogenicity [35]. Cur-
rently, thyroid imaging does not play a routine role in the 
post-treatment follow-up of RIT patients, but thyroid ul-
trasound would be employed if there was a change in the 
size (enlargement) or nodularity of a treated gland [35]. 
Elastography 
Sporea et al found that thyroid stiffness (TS) assessed 
by means of ARFI SWE in healthy subjects (2±0.40 
m/s) was significantly lower than in Graves’ disease 
(2.67±0.53 m/s) (p<0.0001) and CAT patients (2.43±0.58 
m/s) (p=0.0002), but the differences were not significant 
between Graves’ disease and CAT patients (p=0.053). 
The optimal cut-off value for the prediction of diffuse 
thyroid pathology was 2.36 m/s. For this cut-off value, 
TS had 62.5% sensitivity, 79.5% specificity, 87.6% pre-
dictive positive value, 55.5% negative predictive value, 
and 72.7% accuracy for the presence of diffuse thyroid 
gland pathology (AUROC=0.804). There were no sig-
nificant differences between the TS values obtained with 
linear vs convex probes and when 5 vs 10 measurements 
were taken in each lobe (median values). ARFI SWE 
seems to be a useful method for the evaluation of diffuse 
thyroid gland pathology and is able to predict with suf-
ficient accuracy the presence of diffuse thyroid diseases 
(AUROC=0.80) [46,47].
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on Graves’ disease.
Tips and tricks 
Thyroid scintigraphy is often used in cases where the 
cause of the hyperthyroidism is unclear and to evaluate 
thyroid nodules before treatment [35].
c) Subacute granulomatous thyroiditis 
(De Quervain or granulomatous thyroiditis)
The clinical scenario differs in that the patient pre-
sents with a painful swelling in the lower neck, fever, and 
sometimes lethargy; typically following a viral illness. 
Typically no hyperthyroidism is observed. The biochem-
istry in the acute phase might appear as thyroid toxic-
ity, sometimes followed by a period of hypothyroidism. 
Typically (after a period of 6 – 18 months from acute 
onset) the patient recovers and becomes euthyroid. Suba-
cute granulomatous thyroiditis (SGT) is a self-limiting 
subacute inflammatory disease of the thyroid [57]. It typ-
ically occurs in the area of the gland in mid-aged hyper-
thyroid women complaining of pain, tenderness, fatigue 
and mild fever [58] and constitutes nearly 3-6% of all 
thyroid diseases. Generally appears 2 weeks after a viral 
upper respiratory tract infection and regresses spontane-
ously within 2-3 months. Although its etiology remains 
unknown, it is believed have a viral origin, similar to the 
mumps virus, hepatitis B and C viruses, cytomegalovi-
rus, enterovirus, and type A and B coxsackie viruses. 
Clinically, patients present with localized anterior neck 
pain associated with glandular tenderness and diffuse 
pain in the ears and the jaw, which might be accompa-
nied by fatigue, weight loss, low-grade fever, elevated C-
Reactive Protein (CRP), elevated erythrocyte sedimenta-
tion rate, suppression in the TSH level and occasionally 
dysphagia [59]. 
Conventional B-mode ultrasound 
Characteristic US findings include ill-defined, moder-
ately or markedly patchy hypoechoic areas in the thyroid. 
Hypoechoic areas tend to elongate along the long axis of 
Fig 9. Thyroid inferno. A 44 year old female 
with known Graves’ disease. Sagittal US 
through the left lobe shows a significantly hy-
pervascular gland with the appearance suggest-
ing an inferno hence called as “thyroid inferno”.
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the thyroid. In severe disease, the capsule can be expand-
ed in the affected regions [60]. Generally, an increase in 
the size of the thyroid and heterogeneous, diffuse, hypo-
echoic and confluent areas with negative margins, char-
acteristically defined as “lava flow,” are observed on US 
(fig 10) [59,61,62]. Hypoechoic appearance can also be 
seen in malignancy, however other features like calcifica-
tions and taller than wide shape are absent. Short-term 
follow up is useful to document regression or resolution. 
In addition, a prompt clinical response to anti-inflamma-
tory therapy is highly diagnostic.
In the acute phase, US can detect a hypoechoic ill-
defined mass, usually tender. The adjacent thyroid tis-
sue is heterogeneous in echotexture. In the subacute 
phase, the hypoechoic area increases in size to involve 
the ipsilateral thyroid lobe and sometimes extends to the 
contralateral lobe. And during recovery phase, thyroid 
appearances returns to normal or atrophy may develop 
[62]. Typically, enlarged and activated lymph nodes can 
be found on US as well.
Color Doppler imaging 
No increase in vascularity occurs at CDI. However, 
these findings are nonspecific because they may also be 
seen in CLT, multinodular goiter, and Graves’ diseases, 
and the clinical findings may assist in the differential di-
agnosis [59,62]. 
On CDI, the hypoechoic lesions show reduced or ab-
sent vascularity, whereas the remaining thyroid displays 
normal vascularity. Peak systolic velocity of the afferent 
arteries is typically normal [63].
The sonographic changes described above are no 
longer demonstrable after complete remission of the dis-
ease.
Elastography 
Stiff areas are seen in the thyroid gland in SGT and 
these stiff areas can be stiffer comparing with chronic 
thyroiditis, resembling malignant nodules on elastogra-
phy (fig 11) [64,65]. Xie et al found that real-time strain 
US elastography does not provide conclusive informa-
tion in the diagnosis and differential diagnosis of SGT 
due to its inability to distinguish between this pathology 
and thyroid cancer [64].
Yang et al found that the SR (mean±standard devia-
tion) (calculated by using the sternocleidomastoid muscle 
on the same side of the thyroid as the reference tissue) of 
patients with hyperthyroidism, Hashimoto’s thyroiditis, 
and SGT were 2.30±1.08, 7.04±7.74, and 24.09±13.56, 
respectively. The SR of the control group was 1.76±0.54. 
SR values ranked in ascending order were control group, 
hyperthyroidism group, Hashimoto’s thyroiditis group, 
SGT group. There were statistically significant (p<0.05) 
differences in thyroid hardness between groups with dif-
ferent diffuse thyroid diseases [29]. 
Thyroid tissue stiffness was higher in SGT at baseline 
(214.26±32.5 kPa) in comparison with values recorded 
at a 4-week follow-up (45.92±17.4 kPa) and at 10 weeks 
following diagnosis and treatment initiation (21.65±5.3 
kPa, p<0.0001). Baseline thyroid stiffness in SGT was 
higher than in CAT (36.15±18.7 kPa, p<0.0001) and 
healthy control subjects (16.18±5.4 kPa, p<0.0001). In 
the remission of SGT, thyroid stiffness was lower than 
that found in CAT (p=0.006), and higher comparing with 
healthy control subjects (p=0.0008) [66]. 
Subacute inflammatory pseudonodules were found 
to have greater stiffness comparing with nodules found 
in chronic thyroiditis, and in this condition, elastography 
could be unable to detect thyroid cancer [66].
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on subacute granu-
lomatous thyroiditis.
Tips and tricks 
SGT may be diagnosed conclusively by B mode 
ultrasound in 90% of cases if the clinical picture is 
Fig 10. Subacute granulomatous thyroiditis. A 
32 year old male with subacute granulomatous 
thyroiditis. Transverse US image through the 
right lobe shows patchy hypoechoic areas (ar-
rowheads) in the thyroid gland which did not 
conform to nodules on the sagittal image.
Fig 11. A 38 year old female with cytology 
proven subacute granulomatous thyroiditis. 
Elastography with ARFI showed a very hard 
thyroid gland with stiffness measurement 
of  >8 m/s.
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typical. Rarely, other thyroid diseases with hypoechoic 
echo texture must be considered, and CDI contributes 
with important additional information towards the dif-
ferential diagnosis. Complementary US guided FNA, 
demonstrating giant cells and histiocytes, confirms the 
diagnosis and may be helpful in unclear cases. Scintigra-
phy, as in other cases of thyroid inflammation, does not 
contribute any additional information and should not be 
performed [38].
d) Riedel struma
Riedel’s struma (fibrosing thyroiditis) is an extremely 
rare, local manifestation of a systemic form of fibroscle-
rosis. Most patients with Riedel’s thyroiditis (RT) are be-
tween 30 and 50 years old at the time of diagnosis [67]. It 
is a rare inflammatory disease that results in fibrosis of the 
thyroid gland and invasion to the surrounding structures 
of the neck [68]. Although the etiology of RT is unclear, 
the most probable cause is an autoimmune process [69]. 
The condition is associated with extensive fibrosis in the 
gland that spreads to the neighboring tissues and is asso-
ciated with the presence of inflammatory cell infiltrates. 
It is characterized by an increasingly massive fibrous al-
teration of the thyroid and the surrounding tissues, re-
sulting in indolent hard swelling of the neck [70]. RT is 
more common in females, with an operative incidence of 
0.06% reported. The disease is frequently associated with 
fibrosis of the mediastinum and retroperitoneum, similar 
to IgG4-mediated disease such as Ormond’s disease [71].
Conventional B-mode ultrasound 
US shows an enlarged, hypoechoic gland or with a 
coarsened echotexture with fibrous septations resulting 
in pseudonodular appearance (fig 12a) [72]. Perithyroid 
extension is present [73-75].
Color Doppler imaging 
Previously published CDI features of RT include a 
decrease in vascular flow [76], or only slight vasculari-
zation of the mass (fig 12 b) [73]. The US vascular en-
casement and improvement with corticosteroid treatment 
clearly appear to be specific to RT [75].
Elastography 
Elastography showed heterogeneity in the stiffness 
values of the thyroid parenchyma varying between 21 
kPa and 281 kPa. USE revealed heterogeneity in the stiff-
ness values of the thyroid parenchyma. It should be noted 
that the hypoechoic areas corresponded to the highest 
stiffness values. These areas could correspond to a high 
degree of fibrosis. Longer follow-up times are necessary 
to evaluate the extent to which corticosteroid treatment 
can alter such stiffness values [75]. 
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on RT.
Tips and tricks 
Currently, there are no well-established cytomorpho-
logic criteria published in the literature in RT [77].
e) Post partum thyroiditis
Post-partum thyroiditis (PPT) is a special form of auto-
immune thyroiditis, which occurs in the first year after par-
turition. PPT is characterized by transient hyperthyroidism 
followed by transient hypothyroidism during the first six 
postpartum months. It is seen in 5-9% of women and re-
curred in 75% of cases in subsequent pregnancies, often 
being not recognized because the symptoms of hyperthy-
roidism (1-3 months post partum) and of slight hypothy-
roidism (4-10 months post partum) are misinterpreted as 
puerperal depression or as a [78]. The disease is self-limit-
ing, and thyroid function commonly returns to normal af-
ter one year; permanent hypothyroidism is rare. Diagnosis 
is based upon clinical manifestations and thyroid function 
tests (TSH and free T4). Assessment of anti-TPO antibod-
ies may also help in the diagnosis and thyrotropin receptor 
antibodies (TRAB) should be negative [79].
Conventional B-mode ultrasound 
Typically the gland appears hypoechoic either diffuse 
or with multifocal areas of low echogenicity scattered 
throughout both lobes of the thyroid resulting in a heter-
ogenous appearance [80]. 
Color Doppler imaging 
In comparison to Graves’ disease, there is no ‘vas-
cular inferno’. In older studies, blood flow is reported 
to be mostly reduced and increased vascularity is rare. 
Peak systolic velocity is normal [38]. However, depend-
ing on US-devices used, an increased blood flow can be 
detected very similar to that seen in the acute phase of 
Hashimoto´s disease.
Elastography 
To date, no specific papers, to the best of our knowl-
edge have been published focusing on postpartum thy-
roiditis.
Fig 12. Riedels Thyroiditis. B mode image showing a hetero-
geneous thyroid parenchyma with macro calcifications. There 
is no discrete nodule and the entire gland is involved. The linear 
echogenic ‘streaks’ represent fibrotic bands. Vascularity was 
mainly peripheral, whereas centrally it is reduced
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Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on postpartum thy-
roiditis.
Tips and tricks 
Scintigraphy does not have any role in diagnosis or 
follow up of patients with PPT, especially since the post-
partum patients might be breastfeeding her child, which 
is a contraindication to radioiodine administration. Nei-
ther is biopsy recommended in these patients, unless a 
concomitant focal lesion is seen.
f) Silent thyroiditis
Silent thyroiditis is a rare painless disease. Slight hy-
pothyroidism is clinically apparent, seldom followed by 
hypothyroidism. Anti-TPO antibodies are often low and 
only temporarily present. The disease shows spontaneous 
remission within a few months [81].
Conventional B-mode ultrasound 
Sonographic findings equal post-partum thyroiditis 
[82].
Color Doppler imaging 
No specific information has been listed in the litera-
ture in regards to CDI in silent thyroiditis. From personal 
experience it can be reported that an increased blood 
flow can be detected very similar to that seen in the acute 
phase of Hashimoto´s or postpartum thyroiditis.
Elastography 
To date, no specific papers, to the best of our knowl-
edge have been published focusing on silent thyroiditis.
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on silent thyroiditis.
Tips and tricks 
Because silent thyroiditis might show US features 
very similar to other forms of hyperthyroidism, a radi-
oscan can be helpful in differentiating silent thyroiditis 
from TRAB negative Graves’ disease or a diffuse auton-
omy. Scintigraphy during the hyperthyroid phase of thy-
roiditis would show low values for radioiodine uptake, 
usually less than 1% compared with high values seen in 
Graves’ disease. This can help in differentiating between 
the two diseases [83].
g) Varia: Amiodaron and interferon induced 
thyroid disease
Amiodarone is a potent iodine-rich drug; however, 
side effects on the thyroid and other organs may coun-
terbalance its beneficial effects on the heart. It can cause 
isolated abnormalities of thyroid function tests and overt 
thyroid dysfunction, either hypothyroidism (amiodar-
one-induced hypothyroidism [AIH]) or thyrotoxicosis 
(amiodarone-induced thyrotoxicosis [AIT] [84]). It may 
develop early on or after many years of amiodarone treat-
ment, sometimes following drug withdrawal due to pro-
longed tissue storage of iodinated amiodarone metabo-
lites [85].
AIH occurs more frequently than AIT in iodine-suf-
ficient areas. In contrast to AIT, AIH is more frequent in 
females with a female to male ratio of 1.5:1 [86]. AIH 
patients are also older than AIT with circulating thyroid 
autoantibodies seen in almost 53% of AIH patients with 
underlying thyroid abnormalities especially Hashimoto’s 
thyroiditis [87]. 
Males are more frequently affected by AIT (M/F ratio 
3:1). Incidence has been reported to range between 1% 
and 23% [88]. 15-20% of patients on amiodarone treat-
ment develop either AIT or hypothyroidism. Two types 
of AIT are present; type 1 is a form of iodine-induced 
hyperthyroidism that develops in abnormal glands (mul-
tinodular goiter or latent Graves’ disease). The thyrotoxi-
cosis in this type is caused by excessive thyroid hormone 
synthesis and is treated with anti-thyroid drugs. The more 
common type 2 AIT occurs in patients without underly-
ing thyroid disease. Thyrotoxicosis in these patients is 
caused by amiodarone-induced destructive thyroiditis; 
the disease is treated with steroids [89].
In addition, thyroid disease is a common side effect 
of interferon-based antiviral therapy for chronic hepati-
tis C, which may lead to dose reduction or discontinu-
ation of therapy. The two entities observed are destruc-
tive forms of thyroiditis as well as INF-induced Graves’ 
disease [90]. 
Conventional B-mode ultrasound 
In patients with AIT type 1, US shows a diffuse or 
nodular goiter (fig 13), while in patients with AIT type 2, 
ultrasound shows a normal or small diffuse goiter. US-
findings of IFN-induced thyroid disease are similar to the 
entities observed without IFN.
Color Doppler imaging 
CDI has been shown to be a useful tool in differenti-
ating type 1 AIT from type 2. Using a classification that 
subdivides CDI features into four patterns (0–III), some 
Fig 13. A 69 year old male patient with known cardiac disease 
being treated with Amiodarone. Patient had initially hyperthy-
roidism and hence was sent for a thyroid US which showed an 
echogenic appearing thyroid lobe with no nodules.
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authors have reported that CDI showed mild to markedly 
increased flow in the thyroid in patients with AIT type 1, 
whereas flow within the thyroid is markedly decreased 
or absent in patients with AIT type 2 [91-93]. Moreover, 
the analysis of nodular and extranodular blood flow was 
useful in the definition of the underlying thyroid diseases 
in type 1 AIT, being able to differentiate toxic multinodu-
lar goiter and toxic adenoma from Graves’ disease [91]. 
This differentiation appeared to be of clinical relevance 
regarding therapeutic choice and outcome [94,95]. Sepa-
rate evaluation of parenchymal blood flow from that of 
nodules may prove beneficial in the diagnosis of under-
lying thyroid diseases in patients with type 1 AIT [91].
In IFN-induced thyroid disease, a reduction in echo-
genicity suggestive for a destructive process of the thy-
roid gland was observed on US even before changes in 
thyroid function of antibody status could be measured. 
Risk factors for the development of thyroid dysfunction 
were age, female gender, pre-treatment thyroid volume, 
pre-existing thyroglobulin/thyroid peroxidase antibodies 
and viral load. Power-Doppler ultrasound could reliably 
differentiate between destructive thyroiditis and Graves’ 
disease [90].
Elastography 
To date, no specific papers, to the best of our knowl-
edge have been published focusing on Amiodarone in-
duced thyrotoxicosis
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on Amiodarone in-
duced thyrotoxicosis
Tips and tricks 
Scintigraphy can differentiate between the two forms 
of AIT with positive scans seen in AIT 1 and negligible 
uptake seen in AIT II [96].
h) Acute thyroiditis 
Acute thyroiditis is a very rare disease, predominant-
ly occurring in immuno-suppressed patients. It may de-
velop locally or hematogenically in septicemia. The clas-
sical symptoms of a florid inflammation with fever, sore 
throat, painful swelling, reddening of the skin and lymph 
node enlargement can be found [38]. Acute suppurative 
thyroiditis is uncommon due to the excellent lymphatic 
drainage, encapsulation, and high iodine content in the 
gland. It usually affects children and young adults with 
congenital fourth branchial pouch sinus tracts [27].
Conventional B-mode ultrasound 
Conventional US scan depicts ill-defined thyroid 
borders, the echo texture is inhomogeneous; hypoechoic 
and anechoic areas represent colliquation. In most cases, 
lymph nodes with inflammatory changes may be demon-
strated [38]. US findings are nonspecific and the gland 
may appear enlarged and hypoechoic due to inflamma-
tion. Focal fluid collection with bright echoes in it from 
gas can suggest an abscess [48].
Color Doppler imaging 
May show normal or increased blood flow.
Elastography 
To date, no specific papers, to the best of our knowl-
edge have been published focusing on acute thyroiditis
Contrast enhanced ultrasound
To date, no specific papers, to the best of our knowl-
edge have been published focusing on acute thyroiditis
Tips and tricks 
FNA confirms the diagnosis by identifying the causa-
tive pathogen. If clinical and sonographic findings are 
inconclusive, other forms of thyroiditis or malignant tu-
mor might have to be excluded by cytological examina-
tion. Acute thyroiditis may usually be cured by antibi-
otic therapy. In advanced stages with abscess formation, 
local drainage or even surgery might become necessary 
[38,97].
Conclusion
A wide spectrum of DTD’s affect the thyroid gland 
and US is not generally required for the diagnosis of 
DTD. In some cases, like Hashimoto’s thyroiditis, US 
helps exclude focal thyroid disease in these patients and 
in assessing the size of the thyroid gland. US contrast 
and elastography is in its infancy and larger studies are 
needed to evaluate the utility of these new techniques 
in diffuse thyroid diseases. We also refer to the recently 
published World Federation in Ultrasound and Medicine 
(WFUMB) thyroid elastography guidelines [98].
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